Clinical Trials Logo

Muscle Loss clinical trials

View clinical trials related to Muscle Loss.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04206436 Active, not recruiting - Cystic Fibrosis Clinical Trials

CFTR Modulator Effects on Bone and Muscle in Adults With Cystic Fibrosis

Start date: December 18, 2019
Phase:
Study type: Observational

Study is looking at the effects of cystic fibrosis treatment on bone muscle.

NCT ID: NCT03721497 Active, not recruiting - Clinical trials for Bariatric Surgery Candidate

Testosterone in Bariatric Patients

Start date: December 17, 2020
Phase: Phase 4
Study type: Interventional

Bariatric surgery is an effective method in the treatment of severe obesity and type 2 diabetes mellitus achieving high remission rates. However, weight loss also causes loss of skeletal muscle and bone mass which at least partly could be prevented by exercise and dietary intervention although the counselling of obese and sedentary individuals in order to increase their physical activity presents a challenge. As up to 78.8% of men undergoing bariatric surgery have low levels of testosterone, testosterone therapy could be considered an attractive alternative or supplement to prevent the immense loss of muscle mass during weight loss. Furthermore, low testosterone levels are associated with sarcopenia, insulin resistance, increased body fat, reduced quality of life, loss of libido and reduced sexual function. The study is a long-term randomized, placebo-controlled trial investigating the effects of testosterone therapy combined with exercise and diet counselling on body composition, components of the metabolic syndrome, hormones, inflammation, sexual function and quality of life before and after weight loss in obese, hypogonadal men undergoing bariatric surgery.

NCT ID: NCT02123641 Active, not recruiting - Physical Activity Clinical Trials

Physical Activity as Intervention Against Age-related Loss of Muscle Mass and Function

LISA
Start date: April 2014
Phase: N/A
Study type: Interventional

A minimum of 450 healthy individuals (62-70 years old) will be recruited. Each individual will be randomized into one of three groups stratified according to gender (M/F), BMI (≤28/>28), and 30 sec chair stand (≤11/>11). The three groups are Heavy resistance training (n=150), moderate intensity training (n=150), and control (n=150, no training). Assessments will be performed at baseline, after 12 months of intervention. Furthermore, follow up will be performed after 2,4,7, and 10 years. The primary outcome is change in leg extensor power after the intervention and during follow up. The primary hypothesis is that by applying the intention-to-treat analysis, the moderate intensity training group will increase leg extensor power just as much as the heavy resistance training group. The two training groups will increase muscle power more than the control group.